What is the Liverpool Cancer Research Institute?
The Liverpool Cancer Research Institute (LCRI) is a new strategic initiative which aims to consolidate the existing strengths in biomedical and translational cancer research in Liverpool, grow its capability and accelerate the translation of research into improved patient outcomes.
What are the new cancer drugs in the interaction checker?
Three cancer drugs have been added to the interaction checker. Capecitabine, cetuximab and panitumumab are now listed in the interaction checker as cancer drugs and interactions can be found for all the c
What do we know about drug-drug interactions in cancer?
Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University,